PROTECTIVE MECHANISM OF HERPES SIMPLEX VIRUS ANTIBODY
单纯疱疹病毒抗体的保护机制
基本信息
- 批准号:3264566
- 负责人:
- 金额:$ 15.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-04-01 至 1993-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alphaherpesvirinae T lymphocyte antiantibody antiviral antibody cellular immunity cornea disorder cytotoxicity disease /disorder model enzyme linked immunosorbent assay eye infections fluorescence glycoproteins humoral immunity immunization immunoglobulins laboratory mouse monoclonal antibody ocular herpes passive transport radioassay tissue /cell culture virus replication
项目摘要
Herpes simplex virus (HSV) is an important ocular pathogen in
man. Following infection both cellular and humoral immune
responses are elicited. However, the relative contribution that
each makes toward limiting or exacerbating virus infection is
poorly understood. We and other investigators have shown that
passive transfer of HSV-specific monoclonal antibody (mcAb) will
enable the host to resist a lethal challenge dose of virus. More
recently, it has been found that mcAbs specific for HSV
glycoproteins given 24 hours after corneal infection are able to
prevent or ameloriate development of stromal disease and
promote resolution of HSV eye infection.
Using a murine ocular infection model, we propose to investigate
basic aspects of how antibody can control HSV replication.
McAbs specific for HSV glycoproteins, gD, and selected other
glycoproteins, will be purified, characterized, and tested for their
capacity to inhibit HSV replication and promote virus clearance
from corneal tissue of the BALB/c mouse. In conducting this
work, special emphasis will be placed on evaluating the
importance of immunoglobulin isotype and epitope specificity. A
primary goal is to investigate the mechanism(s) by which antibody
can exert its protective effect. The hypothesis to be tested is
that antibody-dependent cellular cytotoxicity is an important
defense mechanism in vivo.
The information gained from these studies will identify properties
anti-HSV antibodies must have in order to protect optimally in
vivo, and provide new insights into the role the humoral immune
response plays in containing virus infection.
单纯疱疹病毒(HSV)是一种重要的眼部病原体,
伙计 感染后,细胞和体液免疫
反应被引出。 然而,相对贡献,
每种方法都有助于限制或加剧病毒感染,
不太了解。 我们和其他调查人员已经证明,
HSV特异性单克隆抗体(McAb)的被动转移将
使宿主能够抵抗致命剂量的病毒攻击。 更
最近发现,HSV特异性McAb
角膜感染后24小时给予糖蛋白能够
预防或减轻间质疾病的发展,
促进HSV眼部感染的消退。
我们建议使用小鼠眼部感染模型进行研究
抗体如何控制HSV复制的基本方面。
对HSV糖蛋白、gD和选定的其他蛋白具有特异性的单克隆抗体
糖蛋白,将被纯化,表征,并测试其
抑制HSV复制和促进病毒清除的能力
从BALB/c小鼠的角膜组织。 进行这项
工作,将特别强调评估
免疫球蛋白同种型和表位特异性的重要性。 一
主要目的是研究抗体
可以发挥其保护作用。 待检验的假设是
抗体依赖性细胞毒性是
体内防御机制。
从这些研究中获得的信息将确定属性
抗HSV抗体必须具有,以便最佳地保护
体内,并提供新的见解的作用,体液免疫
反应在遏制病毒感染中发挥作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT N LAUSCH其他文献
ROBERT N LAUSCH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT N LAUSCH', 18)}}的其他基金
ROLE OF MIP 2 IN HSV 1 INDUCED CORNEAL INFLAMMATION
MIP 2 在 HSV 1 引起的角膜炎症中的作用
- 批准号:
6052727 - 财政年份:1988
- 资助金额:
$ 15.03万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 15.03万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 15.03万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 15.03万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 15.03万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 15.03万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 15.03万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 15.03万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 15.03万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 15.03万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 15.03万 - 项目类别:
Discovery Grants Program - Individual